Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,491 | 15,505 | 22,482 | 12,873 | 11,224 |
| Marketable Securities | N/A | N/A | N/A | 13,920 | N/A |
| Receivables | 24,052 | 9,885 | 7,899 | 8,584 | 5,734 |
| Inventories | 30,148 | 28,479 | 19,863 | 15,042 | 12,788 |
| TOTAL | $75,395 | $55,296 | $51,166 | $51,194 | $30,509 |
| Non-Current Assets | |||||
| PPE Net | 39,231 | 38,132 | 37,696 | 36,600 | 36,974 |
| Investments And Advances | 1,371 | 1,325 | 1,145 | 1,132 | 967 |
| Intangibles | 27,857 | 27,953 | 28,049 | 28,145 | 28,241 |
| Other Non-Current Assets | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| TOTAL | $78,459 | $77,410 | $76,890 | $75,877 | $76,182 |
| Total Assets | $153,854 | $132,706 | $128,056 | $127,071 | $106,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,166 | 1,068 | 1,153 | 1,056 | 1,056 |
| Accounts payable and accrued liabilities | 33,590 | 22,783 | 15,564 | 10,382 | 9,693 |
| Accrued Expenses | 13,620 | 10,872 | 9,043 | 8,627 | 10,570 |
| TOTAL | $55,329 | $42,365 | $30,955 | $25,843 | $27,144 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,489 | 8,854 | 9,035 | 9,394 | 9,643 |
| Other Non-Current Liabilities | 0 | 15,379 | 16,000 | 29,500 | 29,500 |
| TOTAL | $11,384 | $24,233 | $27,476 | $41,631 | $41,562 |
| Total Liabilities | $66,713 | $66,598 | $58,431 | $67,474 | $68,706 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,029 | 57,933 | 53,585 | 52,562 | 47,884 |
| Common Shares | 580 | 553 | 535 | 526 | 479 |
| Retained earnings | -95,501 | -104,549 | -99,447 | -95,839 | -93,555 |
| Other shareholders' equity | 0 | 0 | -3 | -11 | -39 |
| TOTAL | $87,141 | $66,108 | $69,625 | $59,597 | $37,985 |
| Total Liabilities And Equity | $153,854 | $132,706 | $128,056 | $127,071 | $106,691 |